ATE194035T1 - Überwachung von patienten mit dickdarmkrebs durch messung von nca 50/90 im blut - Google Patents

Überwachung von patienten mit dickdarmkrebs durch messung von nca 50/90 im blut

Info

Publication number
ATE194035T1
ATE194035T1 AT94106221T AT94106221T ATE194035T1 AT E194035 T1 ATE194035 T1 AT E194035T1 AT 94106221 T AT94106221 T AT 94106221T AT 94106221 T AT94106221 T AT 94106221T AT E194035 T1 ATE194035 T1 AT E194035T1
Authority
AT
Austria
Prior art keywords
nca
blood
colon cancer
measurement
over time
Prior art date
Application number
AT94106221T
Other languages
English (en)
Inventor
William Jeffrey Allard
Kwok K Yeung
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of ATE194035T1 publication Critical patent/ATE194035T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5753—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the stomach or small intestine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT94106221T 1993-04-21 1994-04-21 Überwachung von patienten mit dickdarmkrebs durch messung von nca 50/90 im blut ATE194035T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5093593A 1993-04-21 1993-04-21
US19397594A 1994-02-08 1994-02-08

Publications (1)

Publication Number Publication Date
ATE194035T1 true ATE194035T1 (de) 2000-07-15

Family

ID=26728869

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94106221T ATE194035T1 (de) 1993-04-21 1994-04-21 Überwachung von patienten mit dickdarmkrebs durch messung von nca 50/90 im blut

Country Status (7)

Country Link
US (1) US6309846B1 (de)
EP (1) EP0628820B1 (de)
JP (1) JP3345696B2 (de)
AT (1) ATE194035T1 (de)
AU (1) AU681624B2 (de)
CA (1) CA2118760C (de)
DE (1) DE69424974T2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2118759C (en) * 1993-04-21 2004-06-22 William Jeffrey Allard Diagnosis and monitoring of lung cancer patients by measurement of nca 50/90 in blood
EP0727664A3 (de) * 1995-02-15 1996-11-20 Bayer Ag Tumormarker für Nachweis des Wiederauftretens eines Brustkrebs
EP0747705A1 (de) * 1995-06-09 1996-12-11 Bayer Corporation Spezifische Bestimmung von NCA 90 Glykoprotein im Blut eines Krebspatienten
WO2001096390A2 (en) * 2000-06-09 2001-12-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
EP2784511A1 (de) * 2013-03-27 2014-10-01 Universität Zürich Integrin-alpha-v-beta 6 zur Diagnose/Prognose von Kolorektalkarzinomen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200316A (en) * 1990-02-15 1993-04-06 Miles Inc. Immunoassay methods using noncross reactive cea gene family members antibodies
CA2082605C (en) * 1991-12-30 2005-02-01 James J. Elting Monitoring of nca-bt in blood samples of breast cancer patients
CA2118759C (en) * 1993-04-21 2004-06-22 William Jeffrey Allard Diagnosis and monitoring of lung cancer patients by measurement of nca 50/90 in blood

Also Published As

Publication number Publication date
JPH06324044A (ja) 1994-11-25
EP0628820B1 (de) 2000-06-21
AU681624B2 (en) 1997-09-04
DE69424974T2 (de) 2000-10-19
EP0628820A2 (de) 1994-12-14
JP3345696B2 (ja) 2002-11-18
CA2118760C (en) 2004-06-22
CA2118760A1 (en) 1994-10-22
EP0628820A3 (de) 1995-09-06
AU5942094A (en) 1994-10-27
US6309846B1 (en) 2001-10-30
DE69424974D1 (de) 2000-07-27

Similar Documents

Publication Publication Date Title
NO163584C (no) Anordning for deteksjon av en bestanddel i en flytende proeve ved maaling av endringer i konduktivitet.
DE69627097D1 (de) Blutglucose-Teststreifen mit reduzierter Sensitivität für Hämatokrit
DE69432976D1 (de) Verffahren zum überwachen der befolgung einer vorgeschriebenen medikation durch einen patienten
US5197017A (en) Potentiophotometric fibrinogen determination
FI941522A0 (fi) Menetelmä hemoglobiiniadditiotuotteiden määrittämiseksi
WO1995009559A3 (en) Detection of an acute myocardial infarction in a patient
IE42546L (en) Method of measuring serum coagulability
Thomas et al. Comparison of venipuncture blood counts with microcapillary measurements in screening for anemia in one-year-old infants
ATE194035T1 (de) Überwachung von patienten mit dickdarmkrebs durch messung von nca 50/90 im blut
ATE195182T1 (de) Überwachung von patienten mit lungenkrebs durch messung von nca 50/90 im blut
SU1013853A1 (ru) Способ определени воспалительного процесса в организме
DE69322242D1 (de) Turbidimetrisches Immunassay mit Messung der Geschwindigkeit der Trübungsveränderung nach dem Anfang der Immunpräzipitationsreaktion
Schneider et al. A gel model for measuring crystallization inhibitor activities
Cheah et al. A rapid and simple blood sugar determination using the Ames reflectance meter and Dextrostix system: a preliminary report
SU1122294A1 (ru) Способ определени нарушени кровообращени в исследуемой сосудистой зоне
ATE155891T1 (de) Immunoassay für nca-bt in blutproben von brustkrebspatientinnen
EP0230343A3 (de) Verfahren zur Bestimmung von Glycerophosphaten in amniotischen Flüssigkeiten als diagnostischer Anzeiger
Adlercreutz et al. Determination of α-amylase in serum and urine of subjects with a low bicarbonate concentration in the duodenal aspirate after secretin stimulation
Shimizu et al. A new automatic method for measuring cell electrophoretic mobility
SU1655468A1 (ru) Способ диагностики стадий печеночной недостаточности
SU1397836A1 (ru) Способ определени интоксикации организма тиомочевиной
SU1666952A1 (ru) Способ контрол эффективности лечени юношеской артериальной гипертензии
JPS6430127A (en) Switching device operation time measuring system
Andreasen Predictive value of decreasing antithrombin III in deep-vein thrombosis
Lizana et al. Electronic timing of a high-speed immunonephelometric continuous-flow system

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties